As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.
6 Analysts have issued a Profound Medical Corp forecast:
6 Analysts have issued a Profound Medical Corp forecast:
| Jun '25 | 
    +/-
   
    %
   | ||
| Revenue | 12 12 | 
      
        
        50%
      
      
        
        50%
      
 | |
| Gross Profit | 8.22 8.22 | 
      
        
        71%
      
      
        
        71%
      
 | |
| EBITDA | -42 -42 | 
      
        
        40%
      
      
        
        40%
      
 | |
| EBIT (Operating Income) EBIT | -42 -42 | 
      
        
        38%
      
      
        
        38%
      
 | |
| Net Profit | -41 -41 | 
      
        
        48%
      
      
        
        48%
      
 | |
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.
| Head office | Canada | 
| CEO | Arun Menawat | 
| Employees | 142 | 
| Founded | 2008 | 
| Website | profoundmedical.com | 
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


